Bio-Techne
TECH
#2229
Rank
โ‚น807.94 B
Marketcap
โ‚น5,164
Share price
-1.88%
Change (1 day)
-7.37%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚น31.91 Billion

According to Bio-Techne's latest financial reports the company's total debt is โ‚น31.91 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-06-30โ‚น38.06 B8.82%
2024-06-30โ‚น34.97 B-6.32%
2023-06-30โ‚น37.33 B45.05%
2022-06-30โ‚น25.73 B-17.7%
2021-06-30โ‚น31.27 B-4.76%
2020-06-30โ‚น32.83 B-5.7%
2019-06-30โ‚น34.82 B50.09%
2018-06-30โ‚น23.20 B4.45%
2017-06-30โ‚น22.21 B245.48%
2016-06-30โ‚น6.43 B31.28%
2015-06-30โ‚น4.89 B530.88%
2014-06-30โ‚น0.77 B
2006-06-30โ‚น0.62 B-2.14%
2005-06-30โ‚น0.63 B-12.43%
2004-06-30โ‚น0.72 B-8.33%
2003-06-30โ‚น0.79 B-10.23%
2002-06-30โ‚น0.88 B-0.9%
2001-06-30โ‚น0.89 B1.03%
2000-06-30โ‚น0.88 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น3.245 T 10,068.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น1.744 T 5,366.31%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น1.864 T 5,740.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น1.533 T 4,703.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น193.46 B 506.22%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
โ‚น0.27 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚น126.90 B 297.64%๐Ÿ‡บ๐Ÿ‡ธ USA